[Explanation] At the 3rd China International Import Expo (hereinafter referred to as CIIE) being held in Shanghai, Johnson & Johnson took "Innovation Driven to Help Healthy China" as the theme, and exhibited a "dual booth" with an exhibition area of ​​more than 1,000 square meters. As an innovative development of medical and health enterprises.

  The public health and epidemic prevention zone was launched for the first time at this CIIE.

As one of the top 500 U.S. companies participating in this exhibition, Johnson & Johnson also actively participated in it, highlighting its unremitting efforts to support public health and anti-epidemic work.

Song Weiqun, senior vice president of Johnson & Johnson and chairman of China, said in an interview with a reporter from China News Agency recently that he hopes that through the platform of the anti-epidemic zone, he hopes to make more efforts for the development of public health with all walks of life.

  [Concurrent] Song Weiqun, Senior Vice President of Johnson & Johnson and Chairman of China

  We hope to use this platform to build publicity for public health, international cooperation between public health, and the reform of public health itself.

Because this public health crisis really awakened the entire human race.

  [Explanation] Song Weiqun pointed out that the past two CIIEs have accelerated the release of spillover effects for Johnson & Johnson. From the perspective of overall business volume, China has gradually become a key market for Johnson & Johnson's global business map, and will continue to increase in the future.

  [Concurrent] Song Weiqun, Senior Vice President of Johnson & Johnson and Chairman of China

  We are in China in the future, especially after this epidemic, we will increase and accelerate our investment, so we will strive to make China (the market) bigger.

  [Explanation] According to Song Weiqun, Johnson & Johnson's business in China has gradually recovered after the epidemic. Since the second quarter, medical equipment, pharmaceuticals, consumer products and all-view businesses have experienced strong growth, leading the global market. Johnson & Johnson's China business has become increasingly important in its global strategic landscape.

For example, the medical equipment business accounts for a double-digit global share, and this is an "unprecedented development."

  Song Weiqun said that many companies regard China as the largest development market, but Johnson & Johnson feels that this is not enough. China should be regarded as a "global innovation engine."

  [Concurrent] Song Weiqun, Senior Vice President of Johnson & Johnson and Chairman of China

  When we were in Beijing in October last year, we announced China's "innovation + development" dual-engine strategy.

And I think the more important thing is that our local comprehensive capabilities should be strengthened, that is, China should become an engine of growth and innovation for the world.

  [Explanation] Song Weiqun said that in the future, Johnson & Johnson will speed up the introduction of the world's top innovative products and accelerate local research and development in China.

In addition to the United States, China is the first market for Johnson & Johnson to have "end-to-end" R&D capabilities in every sector, with more than 700 top scientists and engineers in China.

Johnson & Johnson's R&D center in China is not only "in China for China", but also "in China for the world."

In Song Weiqun's view, the epidemic has given birth to some obvious changes in the Chinese medical market. As the concept of "big health management" gains more recognition after the epidemic, disease prevention and control and health services will become an important part of health management. Changes in the health management cycle will enable more companies to achieve breakthrough development.

  Reporter Li Xiaoyu, Xu Yin, Kang Yuzhan from Shanghai

Editor in charge: [Lu Yan]